J. Papp

4.8k citations

150 papers · 3.5k · 2 hit papers · h-index 30

Impact in

Genetics top 2%
- BRCA gene mutations in cancer
- Inflammatory Bowel Disease
- Genetic Associations and Epidemiology
Pathology and Forensic Medicine top 2%
- Genetic factors in colorectal cancer

Papers in

Genetics 37
- Inflammatory Bowel Disease 15
- BRCA gene mutations in cancer 12
Inorganic Chemistry 15
- Zeolite Catalysis and Synthesis 15

Co-authors: Edith Oláh (16 shared papers)Zsolt Tulassay (16 shared papers)Peter Laszlo Lakatos (26 shared papers)Maria Papp (14 shared papers)Tamás Szamosi (6 shared papers)Zoltán Szentirmay (2 shared papers)Szabolcs Ottó (1 shared paper)Ágota Kovács (9 shared papers)
Journals: Gastrointestinal Endoscopy (5 papers)Inflammatory Bowel Diseases (4 papers)Endoscopy (3 papers)Zeolites (3 papers)International Journal of Molecular Sciences (3 papers)
Partner nations: Hungary Germany United Kingdom

In The Last Decade

J. Papp

137 papers receiving 3.4k citations

J. Papp's Hit Papers

align trajectories log scale

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses 2020 · 303 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2020 Nature Genetics
2015 JAMA

Peers

Countries citing papers authored by J. Papp

Since Specialization

Citations

This map shows the geographic impact of J. Papp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Papp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Papp more than expected).

Fields of papers citing papers by J. Papp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Papp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Papp. The network helps show where J. Papp may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Papp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Papp Line = papers co-authored together J. Papp links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer JAMA ·Timothy R. Rebbeck, Nandita Mitra, Fei Wan, Olga M. Sinilnikova, Sue C. Healey, Lesley McGuffog, Sylvie Mazoyer, Georgia Chenevix‐Trench Hit paper breakdown →	2015	397
2	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses Nature Genetics ·Haoyu Zhang, Thomas U. Ahearn, Julie Lecarpentier, Daniel R. Barnes, Jonathan Beesley, Guanghao Qi, Xia Jiang, Tracy A. O’Mara Hit paper breakdown →	2020	303
3	Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations Human Mutation ·Timothy Richard Rebbeck, Tara M. Friebel, Eitan Friedman, Ute Hamann, Dezheng Huo, Ava Ki-Wa Tin. Kwong, Edith Oláh, Olufunmilayo Ibironke Olopade	2018	242
4	Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study The Lancet Oncology ·Marlies J. E. Kempers, Roland P. Kuiper, Charlotte W. Ockeloen, Pierre Olivier Chappuis, Pierre Hutter, Nils Rahner, Hans K. Schackert, Verena Steinke	2010	226
5	Deletions removing the last exon ofTACSTD1constitute a distinct class of mutations predisposing to Lynch syndrome Human Mutation ·Marietta Eva Kovacs, J. Papp, Zoltán Szentirmay, Szabolcs Ottó, Edith Oláh	2009	135
6	New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort The American Journal of Gastroenterology ·Maria Papp, István Altorjay, Nir Dotan, Károly Palatka, Ildikó Földi, Judit Tumpek, Sándor Sipka, M. Udvardy	2008	128
7	Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes Nature Genetics ·Laura Fachal, Hugues Aschard, Jonathan Beesley, Daniel R. Barnes, Jamie Allen, Siddhartha Kar, Karen A. Pooley, Joe Dennis	2020	120
8	Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s disease World Journal of Gastroenterology ·Peter Laszlo Lakatos, Zsofia Czegledi, Tamás Szamosi, János Banai, Gyula Dávid, Ferenc Zsigmond, Tünde Pandúr, Zsuzsanna Erdélyi	2009	102
9	Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer Nature Communications ·Manuel A. R. Ferreira, Eric R. Gamazon, Fares Al‐Ejeh, Kristiina Aittomäki, Irene Louise Andrulis, Hoda Anton‐Culver, Aðalgeir Arason, Volker Arndt	2019	88
10	Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 Breast Cancer Research ·kConFab Investigators, Valentina Silvestri, EMBRACE, Daniel Barrowdale, Anna Marie Mulligan, Susan L. Neuhausen, Stephen B. Fox, Beth Y. Karlan	2016	85
11	A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2 Nature Genetics ·Susan J. Ramus, Lori Sickels Friedman, Simon A. Gayther, Bruce A.J. Ponder, Lynda G. Bobrow, Marco van der Looji, J. Papp, Edith Olah	1997	75
12	Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohnʼs disease Inflammatory Bowel Diseases ·Peter Laszlo Lakatos, Lajos Sandor Kiss, Károly Palatka, István Altorjay, Péter Antal‐Szalmás, Eszter Pályu, M. Udvardy, Tamás Molnár	2010	74
13	Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. PubMed ·Catherine M. Phelan, Åke Borg, Marguerite Cuny, David N. Crichton, Trausti Baldersson, Tone Ikdahl Andersen, Maria Adelaide Caligo, Rosette Lidereau	1998	73
14	Seroreactivity to microbial components in Crohnʼs disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients Inflammatory Bowel Diseases ·Maria Papp, István Altorjay, Gary L. Norman, Zakera Shums, Károly Palatka, Zsuzsanna Vitális, Ildikó Földi, Gabriella Lakos	2007	71
15	Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease Scandinavian Journal of Gastroenterology ·Agnes Katalin Kocsis, Peter Laszlo Lakatos, Ferenc Somogyvári, Péter Fuszek, J. Papp, Simon Fischer, Tamás Szamosi, Ágota Kovács	2008	63
16	Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohnʼs disease, while smoking decreases the risk of colectomy in ulcerative colitis European Journal of Gastroenterology & Hepatology ·Tamás Szamosi, János Banai, Zsofia Czegledi, Gyula Dávid, Ferenc Zsigmond, Tünde Pandúr, Zsuzsanna Erdélyi, Orsolya Gemela	2010	60
17	Pancreatic Autoantibodies Are Associated with Reactivity to Microbial Antibodies, Penetrating Disease Behavior, Perianal Disease, and Extraintestinal Manifestations, But Not with NOD2/CARD15 or TLR4 Genotype in a Hungarian IBD Cohort Inflammatory Bowel Diseases ·Peter Laszlo Lakatos, István Altorjay, Tamás Szamosi, Károly Palatka, Zsuzsanna Vitális, Judit Tumpek, Sándor Sipka, M. Udvardy	2008	54
18	Claudin expression in Barrett's esophagus and adenocarcinoma Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Hajnalka Győrffy, Ágnes Holczbauer, Pál Nagy, Zsuzsa Szabó, Péter Károly Kupcsulik, Csilla Páska, J. Papp, Zsuzsa Schaff	2005	54
19	ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients Digestive and Liver Disease ·Peter Laszlo Lakatos, Tamas Szamosi, Anikó Szilvási, Edit Molnar, Amir Kovacs, Tünde Molnár, Istvan F. Altorjay, Maria Papp	2008	51
20	Modification of cotton-cellulose by preirradiation grafting Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms ·Erzsébet Takács, László Wojnárovits, Judit Borsa, J. Papp, P. Hargittai, Lászió Korecz	2005	49

About J. Papp

J. Papp is a scholar working on Genetics, Inorganic Chemistry, Surgery, Gastroenterology and Pathology and Forensic Medicine, having authored 150 papers that have together received 3.5k indexed citations. Recurring topics across this work include Zeolite Catalysis and Synthesis (15 papers), Inflammatory Bowel Disease (15 papers), Genetic factors in colorectal cancer (13 papers), BRCA gene mutations in cancer (12 papers), Plant Physiology and Cultivation Studies (12 papers), Pancreatitis Pathology and Treatment (10 papers), Gallbladder and Bile Duct Disorders (9 papers) and Horticultural and Viticultural Research (7 papers). The work is most often cited by research in Genetics (1.5k citations), Pathology and Forensic Medicine (601 citations), Cancer Research (442 citations), Oncology (548 citations) and Gastroenterology (91 citations). J. Papp has collaborated with scholars based in Hungary, Germany and United Kingdom. Frequent co-authors include Edith Oláh, Zsolt Tulassay, Peter Laszlo Lakatos, Maria Papp, Tamás Szamosi, Zoltán Szentirmay, Szabolcs Ottó, Ágota Kovács, D. Kalló and Tamás Molnár. Their work appears in journals such as Gastrointestinal Endoscopy, Inflammatory Bowel Diseases, Endoscopy, Zeolites and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

J. Papp

Impact in

Papers in i

In The Last Decade

J. Papp

J. Papp's Hit Papers

Peers

Countries citing papers authored by J. Papp

Fields of papers citing papers by J. Papp

All Works

About J. Papp

Explore authors with similar magnitude of impact

Papers in